Article 3
During the period 1 January to 31 December 2003 the following rules shall apply: 1. the allocation of essential medical use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 shall be to the companies indicated in Annex II; 2. the allocation of essential laboratory use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115 and other fully halogenated chlorofluorocarbons shall be to the companies indicated in Annex III; 3. the allocation of essential laboratory use quotas for halons shall be to the companies indicated in Annex IV; 4. the allocation of essential laboratory use quotas for carbon tetrachloride shall be to the companies indicated in Annex V; 5. the allocation of essential laboratory use quotas for 1,1,1-trichloroethane shall be to the companies indicated in Annex VI; 6. the allocation of essential laboratory use quotas for hydrobromofluorocarbons shall be to the companies indicated in Annex VII; 7. the allocation of essential laboratory use quotas for bromochloromethane shall be to the companies indicated in Annex VIII; 8. the essential use quotas for chlorofluorocarbons 11, 12, 113, 114 and 115, other fully halogenated chlorofluorocarbons, carbon tetrachloride, 1,1,1-trichloroethane, hydrobromofluorocarbons and bromochloromethane shall be as set out in Annex IX.